Feb 24, 2021
Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data
Jan 07, 2021
ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology
Oct 30, 2020
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
Oct 11, 2020
CStone Announces Completion of $200 million Share Sale to Pfizer
Sep 24, 2020
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
Sep 15, 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Aug 03, 2020
Award-Winning Television Host Meredith Vieira Joins Pfizer's Find Your MBC Voice to Help Empower People Living with Metastatic Breast Cancer to Speak Up
Jul 15, 2020
NCCN Explores Adoption of Biosimilars in Oncology in Collaboration with Pfizer
May 19, 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Apr 09, 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Apr 08, 2020
ISPE award honors new Pfizer facility that expands company's growing portfolio
Mar 30, 2020
Insights into the Global Insomnia Drugs Market to 2025 - Featuring Astellas Pharma, Flynn Pharma & Pfizer Among Others
Mar 26, 2020
Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 18, 2020
IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations
Mar 13, 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Feb 27, 2020
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Feb 27, 2020
Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
Feb 11, 2020
XTANDI® (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC
Dec 23, 2019
Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program
Dec 23, 2019
BioInvent Announces Selection of Second Target and Extension of the Research Collaboration and License Agreement With Pfizer Inc.